| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1818 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 281 | 2021 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 141 | 2020 |
| Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, MA Bilen, V Santos, J Esther, ... Cancer 126 (6), 1208-1216, 2020 | 75 | 2020 |
| Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis GL Di Tanna, AR Khaki, G Theron, K McCarthy, H Cox, L Mupfumi, ... The Lancet Global Health 7 (2), e191-e199, 2019 | 73 | 2019 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 55 | 2020 |
| Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors D Michailidou, AR Khaki, MP Morelli, L Diamantopoulos, N Singh, ... Scientific reports 11 (1), 9029, 2021 | 51 | 2021 |
| Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis DE Rifkin, AR Khaki, NS Jenny, RL McClelland, M Budoff, K Watson, JH Ix, ... American journal of hypertension 27 (6), 801-810, 2014 | 51 | 2014 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| A new prognostic model in patients with advanced urothelial carcinoma treated with first-line immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, ... European urology oncology 4 (3), 464-472, 2021 | 44 | 2021 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Histological subtypes and response to PD-1/PD-L1 blockade in advanced urothelial cancer: a retrospective study NJ Miller, AR Khaki, LN Diamantopoulos, MA Bilen, V Santos, N Agarwal, ... The Journal of urology 204 (1), 63-70, 2020 | 36 | 2020 |
| Efficacy of enfortumab vedotin in advanced urothelial cancer: analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study VS Koshkin, N Henderson, M James, D Natesan, D Freeman, A Nizam, ... Cancer 128 (6), 1194-1205, 2022 | 34 | 2022 |
| Cancer therapy approval timings, review speed, and publication of pivotal registration trials in the US and Europe, 2010-2019 MP Lythgoe, A Desai, B Gyawali, P Savage, J Krell, JL Warner, AR Khaki JAMA Network Open 5 (6), e2216183-e2216183, 2022 | 31 | 2022 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 28 | 2023 |
| The macroscopic rate of nucleic acid translocation by hepatitis C virus helicase NS3h is dependent on both sugar and base moieties AR Khaki, C Field, S Malik, A Niedziela-Majka, SA Leavitt, R Wang, ... Journal of molecular biology 400 (3), 354-378, 2010 | 27 | 2010 |
| Evaluation of a resident-led project to decrease phlebotomy rates in the hospital: think twice, stick once D Wheeler, P Marcus, J Nguyen, A Kwong, AR Khaki, V Valencia, ... JAMA internal medicine 176 (5), 708-710, 2016 | 25 | 2016 |
| Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes LN Diamantopoulos, AR Khaki, P Grivas, JL Gore, GR Schade, AC Hsieh, ... Bladder Cancer 6 (1), 71-81, 2020 | 22 | 2020 |
| Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes SM Esagian, AR Khaki, LN Diamantopoulos, L Carril‐Ajuria, D Castellano, ... BJU international 128 (2), 196-205, 2021 | 21 | 2021 |
| Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium A Elkrief, C Hennessy, NM Kuderer, SM Rubinstein, E Wulff-Burchfield, ... The Lancet Healthy Longevity 3 (3), e143-e152, 2022 | 19 | 2022 |
Leonidas Nikolaos DiamantopoulosUniversity of IoanninaVerified email at cc.uoi.gr
